Autophagy in α-Synucleinopathies-An Overstrained System

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Alpha-synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), share a common hallmark: alpha-synuclein deposits.
• These deposits manifest as Lewy bodies (LBs) in neurons (PD, DLB) or glial cytoplasmic inclusions (GCIs) in oligodendroglia (MSA).
• The precise mechanisms driving intracytoplasmic inclusion formation remain unclear, with impaired autophagy emerging as a potential key factor.

Purpose of the Study:

• To review the involvement of defective autophagy in the pathogenesis of alpha-synucleinopathies.
• To discuss how impaired autophagy contributes to alpha-synuclein aggregation and propagation.
• To explore the link between autophagy dysfunction and neurodegeneration in these diseases.

Main Methods:

• Literature review of studies investigating autophagy markers and alpha-synuclein aggregation in PD, DLB, and MSA.
• Analysis of existing research on the interplay between autophagic machinery and alpha-synuclein.
• Synthesis of evidence regarding the role of autophagy dysfunction in neurodegenerative processes.

Main Results:

• Reduced autophagy is implicated in the aggregation of alpha-synuclein.
• Altered levels of autophagy markers are observed in the brains of patients with PD, DLB, and MSA.
• The exact causal relationship between autophagy dysfunction and alpha-synuclein pathology is still under investigation.

Conclusions:

• Defective autophagy machinery plays a significant role in the formation and propagation of alpha-synuclein aggregates.
• Autophagy dysfunction is a critical component of the neurodegenerative cascade in alpha-synucleinopathies.
• Further research is needed to elucidate whether autophagy dysfunction initiates or exacerbates alpha-synuclein pathology.